Innovative MedTech, Inc.
IMTH
$0.688
$0.31684.95%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -10.88% | 2.98% | -4.59% | 2.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -10.88% | 2.98% | -4.59% | 2.93% |
| Cost of Revenue | -- | -18.47% | -80.68% | -73.78% | -- |
| Gross Profit | -- | 1.01% | 144.74% | 134.03% | -- |
| SG&A Expenses | 1,045.20% | 204.16% | 1,359.39% | 190.78% | -71.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1,045.20% | 100.02% | 181.99% | -3.00% | -93.07% |
| Operating Income | -1,045.20% | -463.15% | -280.38% | 2.18% | 89.94% |
| Income Before Tax | -753.73% | -435.13% | -666.63% | -13.79% | 86.71% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -753.73% | -435.13% | -666.63% | -13.79% | 86.71% |
| Earnings from Discontinued Operations | 73.71% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -497.71% | -435.13% | -666.63% | -13.79% | 80.75% |
| EBIT | -1,045.20% | -463.15% | -280.38% | 2.18% | 89.94% |
| EBITDA | -1,184.56% | -565.64% | -282.54% | 1.83% | 91.05% |
| EPS Basic | -308.99% | -308.97% | -495.63% | -13.76% | 80.74% |
| Normalized Basic EPS | -489.47% | -306.12% | -179.77% | -13.98% | 86.85% |
| EPS Diluted | -308.99% | -308.97% | -478.77% | -7.50% | 80.74% |
| Normalized Diluted EPS | -489.47% | -306.12% | -179.77% | -13.98% | 86.85% |
| Average Basic Shares Outstanding | 46.01% | 31.02% | 28.57% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 46.01% | 31.02% | 28.57% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
